Windlas Biotech Limited (NSE:WINDLAS)
1,020.00
+21.65 (2.17%)
Nov 12, 2026, 3:30 PM IST
| Market Cap | 21.05B +18.1% |
| Revenue (ttm) | 9.93B +19.6% |
| Net Income | 666.97M -0.9% |
| EPS | 31.27 -1.5% |
| Shares Out | 20.64M |
| PE Ratio | 32.62 |
| Forward PE | n/a |
| Dividend | 6.30 (0.62%) |
| Ex-Dividend Date | Jul 16, 2026 |
| Volume | 37,233 |
| Open | 1,005.00 |
| Previous Close | 998.35 |
| Day's Range | 991.05 - 1,020.30 |
| 52-Week Range | 697.40 - 1,181.90 |
| Beta | 0.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2026 |